These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12185441)

  • 21. Susceptibility to daptomycin, quinupristin-dalfopristin and linezolid and some other antibiotics in clinical isolates of methicillin resistant and methicillin sensitive S.aureus from the Oslo area.
    Jørgen B; Merckoll P; Melby KK
    Scand J Infect Dis; 2007; 39(11-12):1059-62. PubMed ID: 17852934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A holistic approach to MRSA eradication in critically ill patients with MRSA pneumonia.
    Wenisch C; Laferl H; Szell M; Smolle KH; Grisold A; Bertha G; Krause R
    Infection; 2006 Jun; 34(3):148-54. PubMed ID: 16804658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of quinupristin/dalfopristin and glycopeptide in severe methicillin-resistant staphylococcal infections failing previous glycopeptide regimens.
    Scotton PG; Rigoli R; Vaglia A
    Infection; 2002 Jun; 30(3):161-3. PubMed ID: 12120943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit.
    Thorburn K; Taylor N; Saladi SM; van Saene HK
    Clin Microbiol Infect; 2006 Jan; 12(1):35-42. PubMed ID: 16460544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus.
    Gonzalez BE; Martinez-Aguilar G; Hulten KG; Hammerman WA; Coss-Bu J; Avalos-Mishaan A; Mason EO; Kaplan SL
    Pediatrics; 2005 Mar; 115(3):642-8. PubMed ID: 15741366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.
    Kopp BJ; Nix DE; Armstrong EP
    Ann Pharmacother; 2004 Sep; 38(9):1377-82. PubMed ID: 15266044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful oral pristinamycin therapy for osteoarticular infections due to methicillin-resistant Staphylococcus aureus (MRSA) and other Staphylococcus spp.
    Ng J; Gosbell IB
    J Antimicrob Chemother; 2005 Jun; 55(6):1008-12. PubMed ID: 15845784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
    Maclayton DO; Hall RG
    Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quinupristin/dalfopristin in vancomycin-resistant Staphylococcus aureus endophthalmitis.
    Stroh EM
    Arch Ophthalmol; 2012 Oct; 130(10):1323-4. PubMed ID: 23044949
    [No Abstract]   [Full Text] [Related]  

  • 30. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan.
    Kohno S; Yamaguchi K; Aikawa N; Sumiyama Y; Odagiri S; Aoki N; Niki Y; Watanabe S; Furue M; Ito T; Croos-Dabrera R; Tack KJ
    J Antimicrob Chemother; 2007 Dec; 60(6):1361-9. PubMed ID: 17913720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors associated with methicillin-resistant Staphylococcus aureus infection in patients admitted to the ED.
    Viallon A; Marjollet O; Berthelot P; Carricajo A; Guyomarc'h S; Robert F; Zeni F; Bertrand JC
    Am J Emerg Med; 2007 Oct; 25(8):880-6. PubMed ID: 17920971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence of quinupristin/dalfopristin resistance among livestock-associated Staphylococcus aureus ST9 clinical isolates.
    Yu F; Lu C; Liu Y; Sun H; Shang Y; Ding Y; Li D; Qin Z; Parsons C; Huang X; Li Y; Hu L; Wang L
    Int J Antimicrob Agents; 2014 Nov; 44(5):416-9. PubMed ID: 25218154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infections.
    Raad I; Hachem R; Hanna H; Afif C; Escalante C; Kantarjian H; Rolston K
    J Antimicrob Chemother; 2004 Apr; 53(4):646-9. PubMed ID: 14998986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature.
    Ruhe JJ; Monson T; Bradsher RW; Menon A
    Clin Infect Dis; 2005 May; 40(10):1429-34. PubMed ID: 15844065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit.
    de la Cal MA; Cerdá E; van Saene HK; García-Hierro P; Negro E; Parra ML; Arias S; Ballesteros D
    J Hosp Infect; 2004 Mar; 56(3):175-83. PubMed ID: 15003664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection.
    Schrenzel J; Harbarth S; Schockmel G; Genné D; Bregenzer T; Flueckiger U; Petignat C; Jacobs F; Francioli P; Zimmerli W; Lew DP;
    Clin Infect Dis; 2004 Nov; 39(9):1285-92. PubMed ID: 15494904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anemia and reversible reticulocytopenia associated with extended quinupristin/dalfopristin.
    Evans PC; Almas JP; Criddle FJ
    Ann Pharmacother; 2004 Apr; 38(4):720-1. PubMed ID: 14766992
    [No Abstract]   [Full Text] [Related]  

  • 38. Incidence of inducible clindamycin resistance in staphylococci: first results from Turkey.
    Azap OK; Arslan H; Timurkaynak F; Yapar G; Oruç E; Gagir U
    Clin Microbiol Infect; 2005 Jul; 11(7):582-4. PubMed ID: 15966979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
    Arnold FW; Wojda B
    J Ky Med Assoc; 2005 May; 103(5):206-10. PubMed ID: 15918650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Key considerations in the treatment of complicated staphylococcal infections.
    Jones RN
    Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():3-9. PubMed ID: 18226084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.